Halae, Analyn .
HRN: 22-82-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
CEFUROXIME 500MG (TAB)
09/10/2023
09/16/2023
PO
500
BID
Nsvd
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes